资源类型：
期刊
WOS体系：
Review
Pubmed体系：
Journal Article;Review
收录情况：
◇ SCIE
文章类型：
论著,综述
作者：
Yang, Yu[1]
*
;
Sun, Juxian[2]
;
Wu, Mengchao[2]
;
Lau, Wan Yee[2,3]
;
Zheng, Shusen[4]
;
Wang, Xue-Hao[5]
;
Chen, Xiaoping[6]
;
Fan, Jia[7]
;
Dong, Jiahong[8]
;
Cai, Jianqiang[9]
;
Chen, Minshan[10]
;
Chen, Yongjun[11]
;
Cheng, Zhangjun[12]
;
Dai, Chaoliu[13]
;
Shan, Jianzhen[14]
;
Du, Cheng-You[15]
;
Fang, Chihua[16]
;
Hu, Heping[17]
;
Ji, Zhili[18]
;
Jia, Weidong[19]
;
Li, Gong[20]
;
Li, Jing[21]
;
Li, Jiangtao[22]
;
Liu, Chang[23]
;
Liu, Fubao[24]
;
Ma, Yong[25]
;
Mao, Yilei[26]
;
Niu, Zuoxing[27]
;
Shen, Jie[28]
;
Shi, Jie[2]
;
Shi, Xuetao[29]
;
Song, Wenjie[30]
;
Sun, Hui-Chuan[7]
;
Tan, Guang[31]
;
Tao, Ran[32]
;
Wang, Xiaohu[33]
;
Wen, Tianfu[34]
;
Wu, Liqun[35]
;
Xia, Jinglin[36]
;
Xiang, Bang-De[37]
;
Yan, Maolin[38]
;
Ying, Mingang[39]
;
Zhang, Ling[40]
;
Zhang, Xuewen[41]
;
Zeng, Zhao Chong[42]
;
Zhang, Yubao[43]
;
Zhang, Zhiwei[44]
;
Zhou, Jie[45]
;
Zhou, Cuncai[46]
;
Zhou, Jun[47]
;
Zhou, Ledu[48]
;
Zhou, Xinmin[49]
;
Zhu, Ji[50]
;
Zhu, Zhenyu[51]
;
Zhang, Qi[52]
;
Li, Qiu[1]
;
Cheng, Shuqun[2]
;
单位：
[1]Sichuan Univ, West China Hosp, Canc Ctr, Dept Med Oncol, Chengdu, Peoples R China
四川大学华西医院
[2]Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 6, Shanghai, Peoples R China
[3]Chinese Univ Hong Kong, Fac Med, Hong Kong, Peoples R China
[4]Shulan Hangzhou Hosp, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Peoples R China
[5]Nanjing Med Univ, Hepatobiliary Ctr, Affiliated Hosp 1, Nanjing, Peoples R China
江苏省人民医院
[6]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan, Peoples R China
外科学系
肝脏外科
华中科技大学同济医学院附属同济医院
[7]Fudan Univ, Dept Liver Surg & Transplantat, Liver Canc Inst,Minist Educ, Zhongshan Hosp,Key Lab Carcinogenesis & Canc Inva, Shanghai, Peoples R China
[8]Tsinghua Univ, Beijing Tsinghua Changgung Hosp BTCH, Sch Clin Med, Dept Hepatobiliary & Pancreas Surg, Beijing, Peoples R China
[9]Chinese Acad Med Sci, Canc Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China
[10]Sun Yat Sen Univ Canc Ctr, Dept Hepatobiliary Surg, Guangzhou, Peoples R China
[11]Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Hepatobiliary Surg, Sch Med, Shanghai, Peoples R China
[12]Southeast Univ, Zhongda Hosp, Dept Hepatobiliary Surg, Nanjing, Peoples R China
[13]China Med Univ, Affiliated Shengjing Hosp, Dept Hepatobiliary & Spleenary Surg, Shenyang, Peoples R China
中国医科大学附属盛京医院
中国医科大学盛京医院
[14]Zhejiang Univ, Dept Med Oncol, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
浙江大学医学院附属第一医院
[15]Chongqing Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Chongqing, Peoples R China
重庆医科大学附属第一医院
[16]First Mil Med Univ, Zhujiang Hosp, Dept Hepatobiliary Surg, Guangzhou, Peoples R China
南方医科大学珠江医院
[17]Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Gastroenterol, Shanghai, Peoples R China
[18]Capital Med Univ, Beijing Anzhen Hosp, Dept Gen Surg, Beijing, Peoples R China
首都医科大学附属安贞医院
[19]Univ Sci & Technol China, USTC, Dept Gen Surg, Affiliated Hosp 1, Hefei, Peoples R China
[20]Tsinghua Univ, Beijing Tsinghua Changgung Hosp BTCH, Sch Clin Med, Dept Radiat Oncol, Beijing, Peoples R China
[21]Third Mil Med Univ, Xinqiao Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China
[22]Zhejiang Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China
[23]Xi An Jiao Tong Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Xian, Peoples R China
[24]Anhui Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Hefei, Peoples R China
[25]Harbin Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Harbin, Peoples R China
[26]PUMC & Chinese Acad Med Sci, Peking Union Med Coll PUMC Hosp, Dept Liver Surg, Beijing, Peoples R China
[27]Shandong Canc Hosp, Dept Gastroenterol, Jinan, Peoples R China
[28]Nanjing Univ, Canc Ctr, Dept Med Oncol, Nanjing Drum Tower Hosp,Med Coll, Nanjing, Peoples R China
[29]Shandong Canc Hosp, Dept Hepatobiliary Surg, Jinan, Peoples R China
[30]Air Force Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian, Peoples R China
[31]Dalian Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Dalian, Peoples R China
大连医科大学附属第一医院
[32]Zhejiang Prov Peoples Hosp, Dept Hepatobiliary Surg, Hangzhou, Peoples R China
[33]Gansu Canc Hosp, Dept Radiat Oncol, Lanzhou, Peoples R China
[34]Sichuan Univ, West China Hosp, Ctr Liver Transplantat, Dept Liver Surg, Chengdu, Peoples R China
四川大学华西医院
[35]Affiliated Hosp Qingdao Univ, Div Hepatobiliary Pancreat Surg, Qingdao, Peoples R China
[36]Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R China
[37]Guangxi Med Univ, Dept Hepatobiliary Surg, Canc Hosp, Nanning, Peoples R China
[38]Fujian Prov Hosp, Dept Hepatobiliary & Pancreat Surg, Fuzhou, Peoples R China
[39]Fujian Med Univ, Fujian Prov Canc Hosp, Dept Abdominal Surg, Teaching Hosp, Fuzhou, Peoples R China
[40]Zhengzhou Univ, Dept Hepatobiliary Surg, Canc Hosp, Zhengzhou, Peoples R China
[41]Second Hosp Jilin Univ, Dept Hepatobiliary & Pancreas Surg, Changchun, Peoples R China
[42]Fudan Univ, Zhongshan Hosp, Dept Radiat Oncol, Shanghai, Peoples R China
[43]Harbin Med Univ, Dept Hepatobiliary Surg, Canc Hosp, Harbin, Peoples R China
[44]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Surg, Wuhan, Peoples R China
外科学系
外科学系
华中科技大学同济医学院附属同济医院
[45]Southern Med Univ, Nanfang Hosp, Dept Hepatobiliary Surg, Guangzhou, Peoples R China
[46]Jiangxi Prov Canc Hosp, Dept Hepatobiliary Surg, Nanchang, Jiangxi, Peoples R China
[47]Beijing Canc Hosp, Dept Med Oncol, Beijing, Peoples R China
[48]Cent South Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Peoples R China
[49]Air Force Med Univ, Xijing Hosp, Dept Gastroenterol, Xian, Peoples R China
[50]Chinese Acad Sci, Dept Radiat Oncol, Canc Hosp Univ, Hangzhou, Peoples R China
浙江省肿瘤医院
[51]Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Med Ctr 5, Beijing, Peoples R China
[52]Sun Yat Sen Univ, Dept Hepatobiliary Surg, Affiliated Hosp 3, Guangzhou, Peoples R China
中山大学附属第三医院
ISSN：
2235-1795
关键词：
Hepatocellular carcinoma
Immune checkpoint inhibitors
Consensus
摘要：
Background: Hepatocellular carcinoma (HCC) is one of the most common malignancies in China. Most HCC patients are first diagnosed at an advanced stage, and systemic treatments are the mainstay of treatment. Summary: In recent years, immune checkpoint inhibitors have made a breakthrough in the systemic treatment of middle-advanced HCC, breaking the single therapeutic pattern of molecular-targeted agents. To better guide the clinical treatment for effective and safe use of immunotherapeutic drugs, the Chinese Association of Liver Cancer and Chinese Medical Doctor Association has gathered multidisciplinary experts and scholars in relevant fields to formulate the "Chinese Clinical Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021)" based on current clinical studies and clinical medication experience for reference in China. Key Messages: The consensus contained 17 recommendations, including the preferred regimen for first- and second-line immunotherapy, evaluation and monitoring before/during/after treatment, management of complications, precautions for special patients, and potential population for immunotherapy. (c) 2022 The Author(s). Published by S. Karger AG, Basel
被引次数：
10
WOS：
WOS:000924586800003
PubmedID：
36589726
中科院(CAS)分区：
出版当年[2021]版：
大类
|
1 区
医学
小类
|
2 区
肿瘤学
2 区
胃肠肝病学
最新[2025]版：
大类
|
1 区
医学
小类
|
2 区
胃肠肝病学
2 区
肿瘤学
JCR分区：
出版当年[2020]版：
Q1
GASTROENTEROLOGY & HEPATOLOGY
Q1
ONCOLOGY
最新[2023]版：
Q1
GASTROENTEROLOGY & HEPATOLOGY
Q1
ONCOLOGY
影响因子：
11.6
最新[2023版]
12.3
最新五年平均
11.74
出版当年[2020版]
9.024
出版当年五年平均
9.72
出版前一年[2019版]
12.43
出版后一年[2021版]
第一作者：
Yang, Yu
第一作者单位：
[1]Sichuan Univ, West China Hosp, Canc Ctr, Dept Med Oncol, Chengdu, Peoples R China
通讯作者：
Li, Qiu;Cheng, Shuqun
推荐引用方式(GB/T 7714)：
Yang Yu,Sun Juxian,Wu Mengchao,et al.Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)[J].LIVER CANCER.2022,11(6):511-526.doi:10.1159/000526038.
APA：
Yang, Yu,Sun, Juxian,Wu, Mengchao,Lau, Wan Yee,Zheng, Shusen...&Cheng, Shuqun.(2022).Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition).LIVER CANCER,11,(6)
MLA：
Yang, Yu,et al."Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)".LIVER CANCER 11..6(2022):511-526
医学